Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,774 public trials 499 recruiting studies

Neuroendocrine Tumors trial results

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Iowa Iowa City, Iowa, United States
  • Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 23 locations
Conditions
Breast Cancer (HR+HER2-), Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • The START Center for Cancer Care San Antonio, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 14 locations
Conditions
Advanced Solid Tumors, Melanoma, Metastatic Melanoma, +11 more
Locations
  • UC Irvine Health Orange, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Hopkins Eye Clinic Hopkins, Minnesota, United States
View all 29 locations
Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • Hefei Binhu Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China